EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy

Jiahui Lin, Zhu Gong, Yingyue Lu, Jiongheng Cai, Junjie Zhang, Jiaheng Tan, Zhishu Huang iD, Shuobin Chen

Molecules · 17.04.2025 · 30 (8) · 1805

DOI: 10.3390/molecules30081805 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 17.04.2025. Verfasst von Jiahui Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, G-Quadruplexes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong, National Nat-ural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G-quadruplex (G4) structures are non-canonical nucleic acid conformations that play crucial roles in gene regulation, DNA replication, and telomere maintenance. Recent studies have highlighted G4 ligands as promising anticancer agents due to their ability to modulate oncogene expression and induce DNA damage. By stabilizing G4 structures, these ligands affect tumor progression. Additionally, they have been implicated in tumor immunity modulation, particularly through the activation and immunogenic cell death induction of the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling pathway. Moreover, their disruption of telomere maintenance and regulation of key oncogenes, such as c-MYC and KRAS, position them as candidates for immune-based therapeutic interventions. Despite their therapeutic potential, challenges remain in optimizing their clinical applications, particularly in patient stratification and elucidating their immunomodulatory effects. This review provides a comprehensive overview of the mechanisms through which G4 ligands influence tumor progression and immune regulation, highlighting their potential role in future cancer immunotherapy strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyG-QuadruplexesHumansLigandsAnimalsSignal Transduction

Stichwörter der Autor:innen

G-quadruplexanticancer agentcancer immunotherapy

Substanzen

Ligands

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.

ORCID-Profile: Zhishu Huang

Förderung

  • Natural Science Foundation of Guangdong
  • National Nat-ural Science Foundation of China
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Lin, J., Gong, Z., Lu, Y., Cai, J., Zhang, J., Tan, J., Huang, Z., & Chen, S. (2025). Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy. Molecules, 30(8), 1805. https://doi.org/10.3390/molecules30081805

Vancouver

Lin J, Gong Z, Lu Y, Cai J, Zhang J, Tan J, et al. Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy. Molecules. 2025;30(8):1805. doi:10.3390/molecules30081805

BibTeX
@article{Lin2025,
  author = {Lin, Jiahui and Gong, Zhu and Lu, Yingyue and Cai, Jiongheng and Zhang, Junjie and Tan, Jiaheng and Huang, Zhishu and Chen, Shuobin},
  title = {Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {8},
  pages = {1805},
  doi = {10.3390/molecules30081805}
}
Kostenlos starten →